<!doctype html>
<html lang="en">
  <head>
    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=UA-77190356-3"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      gtag('config', 'UA-77190356-3');
    </script>

    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="stylesheet" href="https://api.mapbox.com/mapbox-gl-js/v0.53.0/mapbox-gl.css" />
    <link rel="stylesheet" href="./assets/css/libs.bundle.css" />
    <link rel="stylesheet" href="./assets/css/theme.bundle.css" />
    <link rel="stylesheet" href="./assets/css/various.css" />

    <title>Conf42: Harnessing Cloud-Native AI for Real-Time Surveillance of Antibiotic Resistance: Insights from a Phase 3 UTI Treatment Trial</title>
    <meta name="description" content="Everything Cloud Native and Cloud Security. It came from the Cloud!">

    
    <meta name="image" property="og:image" content="https://www.conf42.com/assets/headshots/https://conf42.github.io/static/headshots/Karthik%20Akinapelli_cloud.png">
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Harnessing Cloud-Native AI for Real-Time Surveillance of Antibiotic Resistance: Insights from a Phase 3 UTI Treatment Trial | Conf42"/>
    <meta property="og:description" content="Antibiotic resistance is a ticking time bomb what if AI and cloud-native tech could predict and combat it in real time Discover how cutting-edge analytics transformed a Phase 3 UTI trial, exposing resistance trends and redefining drug efficacy. Don't miss this game-changing fusion of AI and medicine"/>
    <meta property="og:url" content="https://conf42.com/Cloud_Native_2025_Karthik_Akinapelli_intelligence_computation_monitoring"/>
    

    <link rel="shortcut icon" href="./assets/favicon/favicon.ico" type="image/x-icon" />
    <link rel="apple-touch-icon" sizes="180x180" href="./assets/favicon/apple-touch-icon.png">
    <link rel="icon" type="image/png" sizes="32x32" href="./assets/favicon/favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="./assets/favicon/favicon-16x16.png">
    <link rel="manifest" href="./assets/favicon/site.webmanifest">

    

  <!-- Reddit Pixel -->
  <script>
  !function(w,d){if(!w.rdt){var p=w.rdt=function(){p.sendEvent?p.sendEvent.apply(p,arguments):p.callQueue.push(arguments)};p.callQueue=[];var t=d.createElement("script");t.src="https://www.redditstatic.com/ads/pixel.js",t.async=!0;var s=d.getElementsByTagName("script")[0];s.parentNode.insertBefore(t,s)}}(window,document);rdt('init','a2_e019g7ndfhrm', {"optOut":false,"useDecimalCurrencyValues":true,"aaid":"<AAID-HERE>"});rdt('track', 'PageVisit');
  </script>
  <!-- DO NOT MODIFY UNLESS TO REPLACE A USER IDENTIFIER -->
  <!-- End Reddit Pixel -->

  </head>
  <body>

    <!-- NAVBAR -->
    
    <!-- <nav class="navbar navbar-expand-lg navbar-light bg-light"> -->
    <nav class="navbar navbar-expand-lg navbar-dark bg-dark">
    
      <div class="container">
    
        <!-- Brand -->
        <a class="navbar-brand" href="./">
          <img src="./assets/conf42/conf42_logo_black_small.png" class="navbar-brand-img" alt="...">
        </a>
    
        <!-- Toggler -->
        <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation">
          <span class="navbar-toggler-icon"></span>
        </button>
    
        <!-- Collapse -->
        <div class="collapse navbar-collapse" id="navbarCollapse">
    
          <!-- Toggler -->
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation">
            <i class="fe fe-x"></i>
          </button>
    
          <!-- Navigation -->
          <ul class="navbar-nav ms-auto">

            <li class="nav-item dropdown">
              <a class="nav-link dropdown-toggle" id="navbarLandings" data-bs-toggle="dropdown" href="#" aria-haspopup="true" aria-expanded="false">
                Events
              </a>
              <div class="dropdown-menu dropdown-menu-xl p-0" aria-labelledby="navbarLandings">
                <div class="row gx-0">
                  <div class="col-12 col-lg-6">
                    <!-- <div class="dropdown-img-start" style="background-image: url(./assets/splash/OBS2025_Event_Splash.png);"> -->
                    <div class="dropdown-img-start">
                      <!-- Heading -->
                      <h4 class="fw-bold text-white mb-0">
                        Featured event
                      </h4>
                      <!-- Text -->
                      <p class="fs-sm text-white">
                        Observability 2025
                      </p>
                      <p class="fs-sm text-white">
                        Premiere 2025-06-05
                      </p>
                      <!-- Button -->
                      <a href="https://www.conf42.com/obs2025" class="btn btn-sm btn-white shadow-dark fonFt-size-sm">
                        Learn more
                      </a>
                    </div>
                  </div>
                  <div class="col-12 col-lg-6">
                    <div class="dropdown-body">
                      <div class="row gx-0">
                        <div class="col-12">
    
                        
                          <!-- Heading -->
                          <h6 class="dropdown-header mt-5">
                            2025
                          </h6>
                          <!-- List -->
                          
                          <a class="dropdown-item" href="https://www.conf42.com/devops2025">
                            DevOps
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/python2025">
                            Python
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/ce2025">
                            Chaos Engineering
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/cloud2025">
                            Cloud Native
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/llms2025">
                            Large Language Models (LLMs)
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/golang2025">
                            Golang
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/sre2025">
                            Site Reliability Engineering (SRE)
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/ml2025">
                            Machine Learning
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/obs2025">
                            Observability
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/quantum2025">
                            Quantum Computing
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/rustlang2025">
                            Rustlang
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/platform2025">
                            Platform Engineering
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/mlops2025">
                            MLOps
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/im2025">
                            Incident Management
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/kubenative2025">
                            Kube Native
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/js2025">
                            JavaScript
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/prompt2025">
                            Prompt Engineering
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/robotics2025">
                            Robotics
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/devsecops2025">
                            DevSecOps
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/iot2025">
                            Internet of Things (IoT)
                          </a>
                          
                        
                          <!-- Heading -->
                          <h6 class="dropdown-header mt-5">
                            2024
                          </h6>
                          <!-- List -->
                          
                          <a class="dropdown-item" href="https://www.conf42.com/devops2024">
                            DevOps
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/ce2024">
                            Chaos Engineering
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/python2024">
                            Python
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/cloud2024">
                            Cloud Native
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/llms2024">
                            Large Language Models (LLMs)
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/golang2024">
                            Golang
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/sre2024">
                            Site Reliability Engineering (SRE)
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/ml2024">
                            Machine Learning
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/obs2024">
                            Observability
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/quantum2024">
                            Quantum Computing
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/rustlang2024">
                            Rustlang
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/platform2024">
                            Platform Engineering
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/kubenative2024">
                            Kube Native
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/im2024">
                            Incident Management
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/js2024">
                            JavaScript
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/prompt2024">
                            Prompt Engineering
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/devsecops2024">
                            DevSecOps
                          </a>
                          
                          <a class="dropdown-item" href="https://www.conf42.com/iot2024">
                            Internet of Things (IoT)
                          </a>
                          
                        

                          <!-- Heading -->
                          <h6 class="dropdown-header mt-5">
                            Info
                          </h6>
                          <a class="dropdown-item" href="./code-of-conduct">
                            Code of Conduct
                          </a>
    
                        </div>
                      </div> <!-- / .row -->
                    </div>
                  </div>
                </div> <!-- / .row -->
              </div>
            </li>

            <li class="nav-item dropdown">
              <a class="nav-link dropdown-toggle" id="navbarLandings" data-bs-toggle="dropdown" href="#" aria-haspopup="true" aria-expanded="false">
                Community
              </a>
              <div class="dropdown-menu dropdown-menu-l p-0" aria-labelledby="navbarLandings">
                <div class="row gx-0">
                  <div class="col-12 col-lg-3">
                    <div class="dropdown-body">
                      <div class="row gx-0">
                        <div class="col-12">
                          <a class="dropdown-item" href="https://conf42.circle.so/">
                            <b>Community platform login</b>
                          </a>
                          <a class="dropdown-item" href="https://discord.gg/mvHyZzRGaQ" target="_blank">
                            Discord
                          </a>
                          <a class="dropdown-item" href="./hall-of-fame">
                            Hall of Fame
                          </a>
                          <a class="dropdown-item" href="./speakers">
                            Speakers
                          </a>
                          <a class="dropdown-item" href="https://www.papercall.io/events?cfps-scope=&keywords=conf42" target="_blank">
                            Become a speaker (CFPs)
                          </a>
                          <a class="dropdown-item" href="./testimonials">
                            Testimonials
                          </a>
                          <a class="dropdown-item" href="./about">
                            About the team
                          </a>
                        </div>
                      </div> <!-- / .row -->
                    </div>
                  </div>
                </div> <!-- / .row -->
              </div>
            </li>

            <li class="nav-item">
              <a class="nav-link" href="./podcast">
                Podcast
              </a>
            </li>

            <li class="nav-item">
              <a class="nav-link" href="./blog">
                Blog
              </a>
            </li>

            <li class="nav-item">
              <a class="nav-link" href="./sponsor">
                Sponsor
              </a>
            </li>
          </ul>
    
          <!-- Button -->
          <a class="navbar-btn btn btn-sm btn-primary lift ms-auto" href="#register">
            Join the community!
          </a>
    
        </div>
    
      </div>
    </nav>



<style>
.text-selected {
  background-color: #42ba96!important;
  color: white;
}
</style>
	

    <!-- WELCOME -->
    <section class="py-5 py-md-10" style="background-color: #7B2726;">

      <!-- Shape -->
      <div class="shape shape-blur-3 svg-shim text-white">
        <svg viewBox="0 0 1738 487" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M0 0h1420.92s713.43 457.505 0 485.868C707.502 514.231 0 0 0 0z" fill="url(#paint0_linear)"/><defs><linearGradient id="paint0_linear" x1="0" y1="0" x2="1049.98" y2="912.68" gradientUnits="userSpaceOnUse"><stop stop-color="currentColor" stop-opacity=".075"/><stop offset="1" stop-color="currentColor" stop-opacity="0"/></linearGradient></defs></svg>
      </div>

      <div class="container">
        <div class="row justify-content-center">
          <div class="col-12 text-center" data-aos="fade-up">

            <!-- Heading -->
            <h1 class="display-2 fw-bold text-white">
              Conf42 Cloud Native 2025 - Online
            </h1>

            <h2 class="text-white">
              
              <time datetime="2025-03-06">March 06 2025</time>
              
              - premiere 5PM GMT
              
              
            </h2>

            <!-- Text -->
            <p class="lead mb-0 text-white-75">
              
              <!-- Everything Cloud Native and Cloud Security. It came from the Cloud!
 -->
              <script>
                const event_date = new Date("2025-03-06T17:00:00.000+00:00");
                const local_timezone = Intl.DateTimeFormat().resolvedOptions().timeZone;
                const local_date = new Date("2025-03-06T17:00:00.000+00:00");
                // const local_offset = new Date().getTimezoneOffset() / 60;
                // local_date.setHours(local_date.getHours() + local_offset);
                document.getElementById("localtime").innerHTML = local_date + " in " + local_timezone
              </script>
            </p>

            <!-- Buttons -->
            <div class="text-center mt-5">
              
              <a href="#register" class="btn btn-primary shadow lift me-1 mb-3">
                <i class="fe fe-user-check me-2"></i>
                Subscribe to watch
              </a>
              
              
              <a class="btn btn-danger lift mb-3" data-bigpicture='{"ytSrc": "kKneZdbrHMs"}' href="#">
                <i class="fe fe-youtube me-2"></i>
                Watch this talk
              </a>
              
              
              <!-- 
              <a class="btn btn-danger lift mb-3" href="https://www.youtube.com/playlist?list=PLIuxSyKxlQrDi1jv-thhvcy4pJ3sBeUJr" target="_blank">
                <i class="fe fe-youtube me-2"></i>
                Playlist
              </a>
               -->
            </div>

          </div>
        </div> <!-- / .row -->
      </div> <!-- / .container -->
    </section>

    <!-- SHAPE -->
    <div class="position-relative">
      <div class="shape shape-bottom shape-fluid-x svg-shim text-light">
        <svg viewBox="0 0 2880 48" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M0 48h2880V0h-720C1442.5 52 720 0 720 0H0v48z" fill="currentColor"/></svg>
      </div>
    </div>

    
    <!-- VIDEO -->
    <section class="pt-2 sticky">
      <div class="container">
        <div class="row justify-content-center">

          <div id="video-container" class="col-9 col-lg-12 mb-5">

          <!-- Video -->

            <!-- 1. The <iframe> (and video player) will replace this <div> tag. -->
            <div id="player" class="sticky"></div>

            <script>
              
              var transcript = [{"text": "Hello everyone.", "timestamp": "00:00:00,140", "timestamp_s": 0.0}, {"text": "Greetings of the day.", "timestamp": "00:00:01,640", "timestamp_s": 1.0}, {"text": "My name is Karthik Akinnapelli and I hope you\u0027re all doing well.", "timestamp": "00:00:03,560", "timestamp_s": 3.0}, {"text": "Today I\u0027ll be presenting a phase 3 study findings which", "timestamp": "00:00:07,960", "timestamp_s": 7.0}, {"text": "revolutionized UTI treatment.", "timestamp": "00:00:11,980", "timestamp_s": 11.0}, {"text": "Here in this study, solopenum was compared to suprafloxacin for treating", "timestamp": "00:00:14,550", "timestamp_s": 14.0}, {"text": "uncomplicated urinary tract infections.", "timestamp": "00:00:19,919", "timestamp_s": 19.0}, {"text": "This study tackled the critical issue of raising antibiotic resistance", "timestamp": "00:00:22,155", "timestamp_s": 22.0}, {"text": "and offered innovative strategies for managing complex infections.", "timestamp": "00:00:29,495", "timestamp_s": 29.0}, {"text": "The results provide valuable evidence to guide treatment decisions in the", "timestamp": "00:00:34,794", "timestamp_s": 34.0}, {"text": "evolving landscape of UTI resistance.", "timestamp": "00:00:39,074", "timestamp_s": 39.0}, {"text": "Now, moving on to study design, this phase 3 trial was a double", "timestamp": "00:00:41,604", "timestamp_s": 41.0}, {"text": "blind multicenter study conducted across 142 sites in 4 countries.", "timestamp": "00:00:45,954", "timestamp_s": 45.0}, {"text": "It directly compared oral sulopenem to suprafloxacin, focusing on", "timestamp": "00:00:52,474", "timestamp_s": 52.0}, {"text": "real world clinical outcomes in diverse healthcare settings.", "timestamp": "00:00:57,774", "timestamp_s": 57.0}, {"text": "In terms of enrollment, the study included a total of 1671 women with symptomatic", "timestamp": "00:01:02,424", "timestamp_s": 62.0}, {"text": "uncomplicated urinary tract infections.", "timestamp": "00:01:09,454", "timestamp_s": 69.0}, {"text": "transcriptions, representing the primary demographic most", "timestamp": "00:01:11,605", "timestamp_s": 71.0}, {"text": "affected by these infections.", "timestamp": "00:01:15,114", "timestamp_s": 75.0}, {"text": "This study addresses a critical healthcare challenge, particularly in the US,", "timestamp": "00:01:17,424", "timestamp_s": 77.0}, {"text": "where UUTIs account for approximately 30 million antibiotic prescriptions", "timestamp": "00:01:22,994", "timestamp_s": 82.0}, {"text": "annually, making it one of the most common infections requiring antibiotic treatment.", "timestamp": "00:01:28,664", "timestamp_s": 88.0}, {"text": "Now in ciprofloxacin non susceptible pathogens, sulopenum", "timestamp": "00:01:34,654", "timestamp_s": 94.0}, {"text": "clearly demonstrated superiority.", "timestamp": "00:01:39,344", "timestamp_s": 99.0}, {"text": "with 62.", "timestamp": "00:01:41,505", "timestamp_s": 101.0}, {"text": "6 percent success rate compared to ciprofloxacin\u0027s 26.", "timestamp": "00:01:42,474", "timestamp_s": 102.0}, {"text": "6%, with a highly significant p value.", "timestamp": "00:01:47,474", "timestamp_s": 107.0}, {"text": "Now approximately 27 percent of urinary pathogens in the study were found", "timestamp": "00:01:51,024", "timestamp_s": 111.0}, {"text": "to be resistant to ciprofloxacin, highlighting a significant challenge", "timestamp": "00:01:56,834", "timestamp_s": 116.0}, {"text": "in current treatment options.", "timestamp": "00:02:01,794", "timestamp_s": 121.0}, {"text": "This underscores the crucial role of sulopenum in bridging this gap", "timestamp": "00:02:03,954", "timestamp_s": 123.0}, {"text": "by providing clinicians with an essential alternative, particularly", "timestamp": "00:02:08,894", "timestamp_s": 128.0}, {"text": "for patients at a risk of treatment failure and disease progression.", "timestamp": "00:02:13,384", "timestamp_s": 133.0}, {"text": "Now, not only did sulopenum address ciprofloxacin resistant infections.", "timestamp": "00:02:18,384", "timestamp_s": 138.0}, {"text": "But it also demonstrated exceptional efficacy, achieving an 80 percent clinical", "timestamp": "00:02:23,684", "timestamp_s": 143.0}, {"text": "and microbiological cure rate in patients with extensively drug resistant pathogens.", "timestamp": "00:02:29,664", "timestamp_s": 149.0}, {"text": "Those that are resistant to either beta lactams, fluoroquinolones, or Bacrim, etc.", "timestamp": "00:02:36,224", "timestamp_s": 156.0}, {"text": "This highlights solopenem\u0027s potential as a critical treatment option for patients", "timestamp": "00:02:42,234", "timestamp_s": 162.0}, {"text": "with limited or no treatment alternatives.", "timestamp": "00:02:46,954", "timestamp_s": 166.0}, {"text": "Its ability to overcome multiple resistance mechanisms presents a", "timestamp": "00:02:50,254", "timestamp_s": 170.0}, {"text": "valuable oral treatment option.", "timestamp": "00:02:54,394", "timestamp_s": 174.0}, {"text": "Potentially preventing hospitalizations and reducing reliance on last resort", "timestamp": "00:02:57,084", "timestamp_s": 177.0}, {"text": "option which is intravenous antibiotics.", "timestamp": "00:03:02,364", "timestamp_s": 182.0}, {"text": "This makes solopenem a crucial treatment option in managing resistant infections", "timestamp": "00:03:05,174", "timestamp_s": 185.0}, {"text": "while improving patient outcomes and healthcare resource utilization.", "timestamp": "00:03:10,084", "timestamp_s": 190.0}, {"text": "Now diving deep into antibiotic resistance.", "timestamp": "00:03:14,644", "timestamp_s": 194.0}, {"text": "The analysis revealed that 32 percent of isolates were resistant", "timestamp": "00:03:17,479", "timestamp_s": 197.0}, {"text": "to trimethoprim sulfamethoxazole, which is Pactrim, whereas 18 percent", "timestamp": "00:03:22,029", "timestamp_s": 202.0}, {"text": "showed resistance to nitrofuranto, and this is across all pathogen species.", "timestamp": "00:03:27,560", "timestamp_s": 207.0}, {"text": "This highlights a crucial evolution in bacterial defense mechanisms,", "timestamp": "00:03:32,610", "timestamp_s": 212.0}, {"text": "representing a concerning shift in antimicrobial susceptibility patterns.", "timestamp": "00:03:39,119", "timestamp_s": 219.0}, {"text": "These findings emphasize the urgent need for novel therapeutic strategies", "timestamp": "00:03:43,859", "timestamp_s": 223.0}, {"text": "to combat emerging resistant trends and ensure effective treatment options remain", "timestamp": "00:03:48,879", "timestamp_s": 228.0}, {"text": "available for managing uncomplicated UTIs.", "timestamp": "00:03:54,549", "timestamp_s": 234.0}, {"text": "Now, beyond baseline resistance, the study also revealed that 41 percent of", "timestamp": "00:03:58,149", "timestamp_s": 238.0}, {"text": "isolates that were initially susceptible to ciprofloxacin developed resistance", "timestamp": "00:04:04,000", "timestamp_s": 244.0}, {"text": "post treatment, marking a significant shift in susceptibility patterns.", "timestamp": "00:04:09,249", "timestamp_s": 249.0}, {"text": "This alarming rate of acquired resistance not only jeopardizes future", "timestamp": "00:04:14,509", "timestamp_s": 254.0}, {"text": "treatment options for individual patients, but also amplifies the", "timestamp": "00:04:19,519", "timestamp_s": 259.0}, {"text": "broader public healthcare crisis.", "timestamp": "00:04:24,119", "timestamp_s": 264.0}, {"text": "of antibacterial resistance.", "timestamp": "00:04:26,365", "timestamp_s": 266.0}, {"text": "These findings reinforce the urgent need for alternative treatment", "timestamp": "00:04:31,105", "timestamp_s": 271.0}, {"text": "strategies and enhanced antimicrobial stewardship protocols to mitigate the", "timestamp": "00:04:36,404", "timestamp_s": 276.0}, {"text": "accelerating threat of resistance.", "timestamp": "00:04:42,144", "timestamp_s": 282.0}, {"text": "Now, in the overall study population, soloperium demonstrated statistical", "timestamp": "00:04:44,685", "timestamp_s": 284.0}, {"text": "non inferiority to ciprofloxacin.", "timestamp": "00:04:49,914", "timestamp_s": 289.0}, {"text": "overall study population includes both susceptible and non susceptible", "timestamp": "00:04:51,959", "timestamp_s": 291.0}, {"text": "pathogens to ciprofloxacin with a clinical cure rate of 65.", "timestamp": "00:04:56,259", "timestamp_s": 296.0}, {"text": "6 percent for cilopenem compared to 67.", "timestamp": "00:05:00,890", "timestamp_s": 300.0}, {"text": "9 percent for ciprofloxacin.", "timestamp": "00:05:02,930", "timestamp_s": 302.0}, {"text": "Additionally, a secondary analysis revealed that 18 percent of", "timestamp": "00:05:05,809", "timestamp_s": 305.0}, {"text": "patients developed asymptomatic bacteria post treatment.", "timestamp": "00:05:10,079", "timestamp_s": 310.0}, {"text": "with no significant difference between treatment groups.", "timestamp": "00:05:14,524", "timestamp_s": 314.0}, {"text": "This finding suggests that routine follow up urine cultures in asymptomatic", "timestamp": "00:05:17,564", "timestamp_s": 317.0}, {"text": "patients may not be clinically significant, potentially helping to", "timestamp": "00:05:22,664", "timestamp_s": 322.0}, {"text": "reduce unnecessary antibiotic exposure and promote better antimicrobial stewardship.", "timestamp": "00:05:28,434", "timestamp_s": 328.0}, {"text": "Now, sulopenum demonstrated a favorable safety and tolerability profile, with mild", "timestamp": "00:05:34,874", "timestamp_s": 334.0}, {"text": "and transient diarrhea as the only notable adverse event, occurring in about 12.", "timestamp": "00:05:41,344", "timestamp_s": 341.0}, {"text": "4 percent of patients in sulopenum compared to 2.", "timestamp": "00:05:46,934", "timestamp_s": 346.0}, {"text": "5 percent in ciprofloxacin.", "timestamp": "00:05:50,854", "timestamp_s": 350.0}, {"text": "Very importantly, no serious adverse events were attributed to the drug, and", "timestamp": "00:05:52,804", "timestamp_s": 352.0}, {"text": "discontinuation rates remained below 3%.", "timestamp": "00:05:58,434", "timestamp_s": 358.0}, {"text": "This exceptional safety profile positions solipenum as a strong first line treatment", "timestamp": "00:06:01,654", "timestamp_s": 361.0}, {"text": "option for UDTIs, particularly in diverse, patient populations including elderly", "timestamp": "00:06:07,664", "timestamp_s": 367.0}, {"text": "patients and those with comorbidities.", "timestamp": "00:06:14,834", "timestamp_s": 374.0}, {"text": "Additionally, its minimum drug interaction profile and lack of QT", "timestamp": "00:06:17,944", "timestamp_s": 377.0}, {"text": "prolongation further reinforces its suitability for widespread clinical use.", "timestamp": "00:06:23,434", "timestamp_s": 383.0}, {"text": "Now, sulopenum offers significant therapeutic potential for the", "timestamp": "00:06:29,234", "timestamp_s": 389.0}, {"text": "63 percent of patients with beta lactamase non susceptible infections.", "timestamp": "00:06:34,394", "timestamp_s": 394.0}, {"text": "A population that was previously had limited treatment options", "timestamp": "00:06:39,584", "timestamp_s": 399.0}, {"text": "due to antimicrobial resistance.", "timestamp": "00:06:43,694", "timestamp_s": 403.0}, {"text": "The results are particularly promising for the 13.", "timestamp": "00:06:45,984", "timestamp_s": 405.0}, {"text": "5 percent of patients with extended spectrum beta", "timestamp": "00:06:48,814", "timestamp_s": 408.0}, {"text": "lactamase positive infections.", "timestamp": "00:06:52,994", "timestamp_s": 412.0}, {"text": "As sulopenum provides a novel therapeutic approach that effectively overcomes", "timestamp": "00:06:55,654", "timestamp_s": 415.0}, {"text": "traditional resistance mechanisms.", "timestamp": "00:07:01,054", "timestamp_s": 421.0}, {"text": "This could play a crucial role in reducing dependence on last resort antibiotics,", "timestamp": "00:07:03,414", "timestamp_s": 423.0}, {"text": "ultimately improving treatment outcomes and antimicrobial stewardship.", "timestamp": "00:07:11,364", "timestamp_s": 431.0}, {"text": "Coming to future directions, further research is essential to", "timestamp": "00:07:16,324", "timestamp_s": 436.0}, {"text": "explore personalized treatment approaches, gain deeper insights", "timestamp": "00:07:20,644", "timestamp_s": 440.0}, {"text": "into resistance mechanisms.", "timestamp": "00:07:24,974", "timestamp_s": 444.0}, {"text": "and refined clinical guidelines for UTI management.", "timestamp": "00:07:27,069", "timestamp_s": 447.0}, {"text": "Additionally, conducting broader studies in diverse populations will be", "timestamp": "00:07:31,429", "timestamp_s": 451.0}, {"text": "crucial to optimize treatment strategies in the face of rising antibiotic", "timestamp": "00:07:35,769", "timestamp_s": 455.0}, {"text": "resistance, ensuring more effective and targeted therapeutic interventions.", "timestamp": "00:07:40,649", "timestamp_s": 460.0}, {"text": "Now, finally, the key takeaways is that Celebenum has shown strong efficacy", "timestamp": "00:07:47,059", "timestamp_s": 467.0}, {"text": "as an alternative to ciprofloxacin.", "timestamp": "00:07:53,289", "timestamp_s": 473.0}, {"text": "particularly in drug resistant UTIs with over 90 percent, supports its", "timestamp": "00:07:56,119", "timestamp_s": 476.0}, {"text": "role as a, sorry, with over a 90 percent success rates in ciprofloxacin", "timestamp": "00:08:02,269", "timestamp_s": 482.0}, {"text": "non susceptible infections.", "timestamp": "00:08:08,169", "timestamp_s": 488.0}, {"text": "It\u0027s excellent safety profile, with minimal adverse events and low", "timestamp": "00:08:10,049", "timestamp_s": 490.0}, {"text": "discontinuation rates, supports its role as a first line treatment option.", "timestamp": "00:08:14,039", "timestamp_s": 494.0}, {"text": "Moving forward, key priorities include integrating these findings", "timestamp": "00:08:19,769", "timestamp_s": 499.0}, {"text": "into clinical guidelines, ongoing resistance surveillance, and", "timestamp": "00:08:24,649", "timestamp_s": 504.0}, {"text": "developing targeted treatment protocols based on patient specific", "timestamp": "00:08:29,159", "timestamp_s": 509.0}, {"text": "factors and pathogen susceptibility.", "timestamp": "00:08:32,819", "timestamp_s": 512.0}, {"text": "These efforts are essential for enhancing antimicrobial stewardship", "timestamp": "00:08:36,359", "timestamp_s": 516.0}, {"text": "and ensuring effective patient care amid rising antibiotic resistance.", "timestamp": "00:08:41,419", "timestamp_s": 521.0}, {"text": "Thank you so much for giving me this opportunity.", "timestamp": "00:08:47,389", "timestamp_s": 527.0}];
              

              var tag = document.createElement('script');

              tag.src = "https://www.youtube.com/iframe_api";
              var firstScriptTag = document.getElementsByTagName('script')[0];
              firstScriptTag.parentNode.insertBefore(tag, firstScriptTag);

              // 3. This function creates an <iframe> (and YouTube player)
              //    after the API code downloads.
              var player;
              function onYouTubeIframeAPIReady() {
                player = new YT.Player('player', {
                  height: '100%',
                  width: '100%',
                  videoId: 'kKneZdbrHMs',
                  playerVars: {
                    'playsinline': 1
                  },
                  events: {
                    'onReady': onPlayerReady,
                    // 'onStateChange': onPlayerStateChange
                  }
                });
              }
              function onPlayerReady(event) {
                console.log("Player ready");
                var sec = Number(location.href.split("#")[1]);
                if (sec){
                  player.seekTo(sec, true);
                }
                player.playVideo();
                highlightParagraph();
              }
              // find the number of the paragraph
              function findParagraph(sec){
                for (var i = 1; i < transcript.length; i++) {
                  if (transcript[i].timestamp_s > sec){
                    return i - 1;
                  }
                }
                return transcript.length - 1;
              }
              // move the video to the desired second
              function seek(sec){
                if(player){
                  player.playVideo();
                  player.seekTo(sec, true);
                }
                location.href = location.href.split("#")[0] + "#" + sec;
                highlightParagraph(sec);
              }
              // highlight the right paragraph
              var prevParagraph;
              function highlightParagraph(sec) {
                var currentTime = sec;
                if (!currentTime && player) {
                  currentTime = player.getCurrentTime();
                }
                if (!currentTime){
                  console.log("No current time")
                  return;
                }
                var currentParagraph = findParagraph(currentTime);
                if (currentParagraph !== prevParagraph){
                  prevParagraph = currentParagraph;
                  Array.from(document.getElementsByClassName("transcript-chunks")).forEach((e) => {
                    e.classList.remove('text-selected');
                  });
                  var body = document.getElementById("chunk-"+currentParagraph);
                  body.classList.add('text-selected');
                }
              }
              time_update_interval = setInterval(highlightParagraph, 1000);
            </script>
          </div>
        </div> <!-- / .row -->
      </div> <!-- / .container -->
    </section>
    

    <!-- CONTENT -->
    <section class="pt-2">
      <div class="container">
        <div class="row justify-content-center">

          <div class="col-12 mb-5">
            <h1>
              Harnessing Cloud-Native AI for Real-Time Surveillance of Antibiotic Resistance: Insights from a Phase 3 UTI Treatment Trial
            </h1>
            
            <h3 class="bg-white">
              Video size:
              <a href="javascript:void(0);" onclick="resizeVideo(25)"><i class="fe fe-zoom-out me-2"></i></a>
              <a href="javascript:void(0);" onclick="resizeVideo(50)"><i class="fe fe-zoom-in me-2"></i></a>
            </h3>
            
          </div>

          <div class="col-12 mb-5">
            <h3>
              Abstract
            </h3>
<!-- Text -->
<p>Antibiotic resistance is a ticking time bomb what if AI and cloud-native tech could predict and combat it in real time Discover how cutting-edge analytics transformed a Phase 3 UTI trial, exposing resistance trends and redefining drug efficacy. Don&rsquo;t miss this game-changing fusion of AI and medicine</p>
<!-- End Text -->
          </div>

          
          

          <div class="col-12 mb-5">
            <h3>
              Summary
            </h3>
            <ul>
              
            </ul>
          </div>

          <div class="col-12 mb-5">
            <h3>
              Transcript
            </h3>
            <span class="text-muted">
              This transcript was autogenerated. To make changes, <a href="https://github.com/conf42/src/edit/main/./srt/cloud2025_Karthik_Akinapelli.srt" target="_blank">submit a PR</a>.
            </span>
            <div>
            
            <span id="chunk-0" class="transcript-chunks" onclick="console.log('00:00:00,140'); seek(0.0)">
              Hello everyone.
            </span>
            
            <span id="chunk-1" class="transcript-chunks" onclick="console.log('00:00:01,640'); seek(1.0)">
              Greetings of the day.
            </span>
            
            <span id="chunk-2" class="transcript-chunks" onclick="console.log('00:00:03,560'); seek(3.0)">
              My name is Karthik Akinnapelli and I hope you're all doing well.
            </span>
            
            <span id="chunk-3" class="transcript-chunks" onclick="console.log('00:00:07,960'); seek(7.0)">
              Today I'll be presenting a phase 3 study findings which
            </span>
            
            <span id="chunk-4" class="transcript-chunks" onclick="console.log('00:00:11,980'); seek(11.0)">
              revolutionized UTI treatment.
            </span>
            
            <span id="chunk-5" class="transcript-chunks" onclick="console.log('00:00:14,550'); seek(14.0)">
              Here in this study, solopenum was compared to suprafloxacin for treating
            </span>
            
            <span id="chunk-6" class="transcript-chunks" onclick="console.log('00:00:19,919'); seek(19.0)">
              uncomplicated urinary tract infections.
            </span>
            
            <span id="chunk-7" class="transcript-chunks" onclick="console.log('00:00:22,155'); seek(22.0)">
              This study tackled the critical issue of raising antibiotic resistance
            </span>
            
            <span id="chunk-8" class="transcript-chunks" onclick="console.log('00:00:29,495'); seek(29.0)">
              and offered innovative strategies for managing complex infections.
            </span>
            
            <span id="chunk-9" class="transcript-chunks" onclick="console.log('00:00:34,794'); seek(34.0)">
              The results provide valuable evidence to guide treatment decisions in the
            </span>
            
            <span id="chunk-10" class="transcript-chunks" onclick="console.log('00:00:39,074'); seek(39.0)">
              evolving landscape of UTI resistance.
            </span>
            
            <span id="chunk-11" class="transcript-chunks" onclick="console.log('00:00:41,604'); seek(41.0)">
              Now, moving on to study design, this phase 3 trial was a double
            </span>
            
            <span id="chunk-12" class="transcript-chunks" onclick="console.log('00:00:45,954'); seek(45.0)">
              blind multicenter study conducted across 142 sites in 4 countries.
            </span>
            
            <span id="chunk-13" class="transcript-chunks" onclick="console.log('00:00:52,474'); seek(52.0)">
              It directly compared oral sulopenem to suprafloxacin, focusing on
            </span>
            
            <span id="chunk-14" class="transcript-chunks" onclick="console.log('00:00:57,774'); seek(57.0)">
              real world clinical outcomes in diverse healthcare settings.
            </span>
            
            <span id="chunk-15" class="transcript-chunks" onclick="console.log('00:01:02,424'); seek(62.0)">
              In terms of enrollment, the study included a total of 1671 women with symptomatic
            </span>
            
            <span id="chunk-16" class="transcript-chunks" onclick="console.log('00:01:09,454'); seek(69.0)">
              uncomplicated urinary tract infections.
            </span>
            
            <span id="chunk-17" class="transcript-chunks" onclick="console.log('00:01:11,605'); seek(71.0)">
              transcriptions, representing the primary demographic most
            </span>
            
            <span id="chunk-18" class="transcript-chunks" onclick="console.log('00:01:15,114'); seek(75.0)">
              affected by these infections.
            </span>
            
            <span id="chunk-19" class="transcript-chunks" onclick="console.log('00:01:17,424'); seek(77.0)">
              This study addresses a critical healthcare challenge, particularly in the US,
            </span>
            
            <span id="chunk-20" class="transcript-chunks" onclick="console.log('00:01:22,994'); seek(82.0)">
              where UUTIs account for approximately 30 million antibiotic prescriptions
            </span>
            
            <span id="chunk-21" class="transcript-chunks" onclick="console.log('00:01:28,664'); seek(88.0)">
              annually, making it one of the most common infections requiring antibiotic treatment.
            </span>
            
            <span id="chunk-22" class="transcript-chunks" onclick="console.log('00:01:34,654'); seek(94.0)">
              Now in ciprofloxacin non susceptible pathogens, sulopenum
            </span>
            
            <span id="chunk-23" class="transcript-chunks" onclick="console.log('00:01:39,344'); seek(99.0)">
              clearly demonstrated superiority.
            </span>
            
            <span id="chunk-24" class="transcript-chunks" onclick="console.log('00:01:41,505'); seek(101.0)">
              with 62.
            </span>
            
            <span id="chunk-25" class="transcript-chunks" onclick="console.log('00:01:42,474'); seek(102.0)">
              6 percent success rate compared to ciprofloxacin's 26.
            </span>
            
            <span id="chunk-26" class="transcript-chunks" onclick="console.log('00:01:47,474'); seek(107.0)">
              6%, with a highly significant p value.
            </span>
            
            <span id="chunk-27" class="transcript-chunks" onclick="console.log('00:01:51,024'); seek(111.0)">
              Now approximately 27 percent of urinary pathogens in the study were found
            </span>
            
            <span id="chunk-28" class="transcript-chunks" onclick="console.log('00:01:56,834'); seek(116.0)">
              to be resistant to ciprofloxacin, highlighting a significant challenge
            </span>
            
            <span id="chunk-29" class="transcript-chunks" onclick="console.log('00:02:01,794'); seek(121.0)">
              in current treatment options.
            </span>
            
            <span id="chunk-30" class="transcript-chunks" onclick="console.log('00:02:03,954'); seek(123.0)">
              This underscores the crucial role of sulopenum in bridging this gap
            </span>
            
            <span id="chunk-31" class="transcript-chunks" onclick="console.log('00:02:08,894'); seek(128.0)">
              by providing clinicians with an essential alternative, particularly
            </span>
            
            <span id="chunk-32" class="transcript-chunks" onclick="console.log('00:02:13,384'); seek(133.0)">
              for patients at a risk of treatment failure and disease progression.
            </span>
            
            <span id="chunk-33" class="transcript-chunks" onclick="console.log('00:02:18,384'); seek(138.0)">
              Now, not only did sulopenum address ciprofloxacin resistant infections.
            </span>
            
            <span id="chunk-34" class="transcript-chunks" onclick="console.log('00:02:23,684'); seek(143.0)">
              But it also demonstrated exceptional efficacy, achieving an 80 percent clinical
            </span>
            
            <span id="chunk-35" class="transcript-chunks" onclick="console.log('00:02:29,664'); seek(149.0)">
              and microbiological cure rate in patients with extensively drug resistant pathogens.
            </span>
            
            <span id="chunk-36" class="transcript-chunks" onclick="console.log('00:02:36,224'); seek(156.0)">
              Those that are resistant to either beta lactams, fluoroquinolones, or Bacrim, etc.
            </span>
            
            <span id="chunk-37" class="transcript-chunks" onclick="console.log('00:02:42,234'); seek(162.0)">
              This highlights solopenem's potential as a critical treatment option for patients
            </span>
            
            <span id="chunk-38" class="transcript-chunks" onclick="console.log('00:02:46,954'); seek(166.0)">
              with limited or no treatment alternatives.
            </span>
            
            <span id="chunk-39" class="transcript-chunks" onclick="console.log('00:02:50,254'); seek(170.0)">
              Its ability to overcome multiple resistance mechanisms presents a
            </span>
            
            <span id="chunk-40" class="transcript-chunks" onclick="console.log('00:02:54,394'); seek(174.0)">
              valuable oral treatment option.
            </span>
            
            <span id="chunk-41" class="transcript-chunks" onclick="console.log('00:02:57,084'); seek(177.0)">
              Potentially preventing hospitalizations and reducing reliance on last resort
            </span>
            
            <span id="chunk-42" class="transcript-chunks" onclick="console.log('00:03:02,364'); seek(182.0)">
              option which is intravenous antibiotics.
            </span>
            
            <span id="chunk-43" class="transcript-chunks" onclick="console.log('00:03:05,174'); seek(185.0)">
              This makes solopenem a crucial treatment option in managing resistant infections
            </span>
            
            <span id="chunk-44" class="transcript-chunks" onclick="console.log('00:03:10,084'); seek(190.0)">
              while improving patient outcomes and healthcare resource utilization.
            </span>
            
            <span id="chunk-45" class="transcript-chunks" onclick="console.log('00:03:14,644'); seek(194.0)">
              Now diving deep into antibiotic resistance.
            </span>
            
            <span id="chunk-46" class="transcript-chunks" onclick="console.log('00:03:17,479'); seek(197.0)">
              The analysis revealed that 32 percent of isolates were resistant
            </span>
            
            <span id="chunk-47" class="transcript-chunks" onclick="console.log('00:03:22,029'); seek(202.0)">
              to trimethoprim sulfamethoxazole, which is Pactrim, whereas 18 percent
            </span>
            
            <span id="chunk-48" class="transcript-chunks" onclick="console.log('00:03:27,560'); seek(207.0)">
              showed resistance to nitrofuranto, and this is across all pathogen species.
            </span>
            
            <span id="chunk-49" class="transcript-chunks" onclick="console.log('00:03:32,610'); seek(212.0)">
              This highlights a crucial evolution in bacterial defense mechanisms,
            </span>
            
            <span id="chunk-50" class="transcript-chunks" onclick="console.log('00:03:39,119'); seek(219.0)">
              representing a concerning shift in antimicrobial susceptibility patterns.
            </span>
            
            <span id="chunk-51" class="transcript-chunks" onclick="console.log('00:03:43,859'); seek(223.0)">
              These findings emphasize the urgent need for novel therapeutic strategies
            </span>
            
            <span id="chunk-52" class="transcript-chunks" onclick="console.log('00:03:48,879'); seek(228.0)">
              to combat emerging resistant trends and ensure effective treatment options remain
            </span>
            
            <span id="chunk-53" class="transcript-chunks" onclick="console.log('00:03:54,549'); seek(234.0)">
              available for managing uncomplicated UTIs.
            </span>
            
            <span id="chunk-54" class="transcript-chunks" onclick="console.log('00:03:58,149'); seek(238.0)">
              Now, beyond baseline resistance, the study also revealed that 41 percent of
            </span>
            
            <span id="chunk-55" class="transcript-chunks" onclick="console.log('00:04:04,000'); seek(244.0)">
              isolates that were initially susceptible to ciprofloxacin developed resistance
            </span>
            
            <span id="chunk-56" class="transcript-chunks" onclick="console.log('00:04:09,249'); seek(249.0)">
              post treatment, marking a significant shift in susceptibility patterns.
            </span>
            
            <span id="chunk-57" class="transcript-chunks" onclick="console.log('00:04:14,509'); seek(254.0)">
              This alarming rate of acquired resistance not only jeopardizes future
            </span>
            
            <span id="chunk-58" class="transcript-chunks" onclick="console.log('00:04:19,519'); seek(259.0)">
              treatment options for individual patients, but also amplifies the
            </span>
            
            <span id="chunk-59" class="transcript-chunks" onclick="console.log('00:04:24,119'); seek(264.0)">
              broader public healthcare crisis.
            </span>
            
            <span id="chunk-60" class="transcript-chunks" onclick="console.log('00:04:26,365'); seek(266.0)">
              of antibacterial resistance.
            </span>
            
            <span id="chunk-61" class="transcript-chunks" onclick="console.log('00:04:31,105'); seek(271.0)">
              These findings reinforce the urgent need for alternative treatment
            </span>
            
            <span id="chunk-62" class="transcript-chunks" onclick="console.log('00:04:36,404'); seek(276.0)">
              strategies and enhanced antimicrobial stewardship protocols to mitigate the
            </span>
            
            <span id="chunk-63" class="transcript-chunks" onclick="console.log('00:04:42,144'); seek(282.0)">
              accelerating threat of resistance.
            </span>
            
            <span id="chunk-64" class="transcript-chunks" onclick="console.log('00:04:44,685'); seek(284.0)">
              Now, in the overall study population, soloperium demonstrated statistical
            </span>
            
            <span id="chunk-65" class="transcript-chunks" onclick="console.log('00:04:49,914'); seek(289.0)">
              non inferiority to ciprofloxacin.
            </span>
            
            <span id="chunk-66" class="transcript-chunks" onclick="console.log('00:04:51,959'); seek(291.0)">
              overall study population includes both susceptible and non susceptible
            </span>
            
            <span id="chunk-67" class="transcript-chunks" onclick="console.log('00:04:56,259'); seek(296.0)">
              pathogens to ciprofloxacin with a clinical cure rate of 65.
            </span>
            
            <span id="chunk-68" class="transcript-chunks" onclick="console.log('00:05:00,890'); seek(300.0)">
              6 percent for cilopenem compared to 67.
            </span>
            
            <span id="chunk-69" class="transcript-chunks" onclick="console.log('00:05:02,930'); seek(302.0)">
              9 percent for ciprofloxacin.
            </span>
            
            <span id="chunk-70" class="transcript-chunks" onclick="console.log('00:05:05,809'); seek(305.0)">
              Additionally, a secondary analysis revealed that 18 percent of
            </span>
            
            <span id="chunk-71" class="transcript-chunks" onclick="console.log('00:05:10,079'); seek(310.0)">
              patients developed asymptomatic bacteria post treatment.
            </span>
            
            <span id="chunk-72" class="transcript-chunks" onclick="console.log('00:05:14,524'); seek(314.0)">
              with no significant difference between treatment groups.
            </span>
            
            <span id="chunk-73" class="transcript-chunks" onclick="console.log('00:05:17,564'); seek(317.0)">
              This finding suggests that routine follow up urine cultures in asymptomatic
            </span>
            
            <span id="chunk-74" class="transcript-chunks" onclick="console.log('00:05:22,664'); seek(322.0)">
              patients may not be clinically significant, potentially helping to
            </span>
            
            <span id="chunk-75" class="transcript-chunks" onclick="console.log('00:05:28,434'); seek(328.0)">
              reduce unnecessary antibiotic exposure and promote better antimicrobial stewardship.
            </span>
            
            <span id="chunk-76" class="transcript-chunks" onclick="console.log('00:05:34,874'); seek(334.0)">
              Now, sulopenum demonstrated a favorable safety and tolerability profile, with mild
            </span>
            
            <span id="chunk-77" class="transcript-chunks" onclick="console.log('00:05:41,344'); seek(341.0)">
              and transient diarrhea as the only notable adverse event, occurring in about 12.
            </span>
            
            <span id="chunk-78" class="transcript-chunks" onclick="console.log('00:05:46,934'); seek(346.0)">
              4 percent of patients in sulopenum compared to 2.
            </span>
            
            <span id="chunk-79" class="transcript-chunks" onclick="console.log('00:05:50,854'); seek(350.0)">
              5 percent in ciprofloxacin.
            </span>
            
            <span id="chunk-80" class="transcript-chunks" onclick="console.log('00:05:52,804'); seek(352.0)">
              Very importantly, no serious adverse events were attributed to the drug, and
            </span>
            
            <span id="chunk-81" class="transcript-chunks" onclick="console.log('00:05:58,434'); seek(358.0)">
              discontinuation rates remained below 3%.
            </span>
            
            <span id="chunk-82" class="transcript-chunks" onclick="console.log('00:06:01,654'); seek(361.0)">
              This exceptional safety profile positions solipenum as a strong first line treatment
            </span>
            
            <span id="chunk-83" class="transcript-chunks" onclick="console.log('00:06:07,664'); seek(367.0)">
              option for UDTIs, particularly in diverse, patient populations including elderly
            </span>
            
            <span id="chunk-84" class="transcript-chunks" onclick="console.log('00:06:14,834'); seek(374.0)">
              patients and those with comorbidities.
            </span>
            
            <span id="chunk-85" class="transcript-chunks" onclick="console.log('00:06:17,944'); seek(377.0)">
              Additionally, its minimum drug interaction profile and lack of QT
            </span>
            
            <span id="chunk-86" class="transcript-chunks" onclick="console.log('00:06:23,434'); seek(383.0)">
              prolongation further reinforces its suitability for widespread clinical use.
            </span>
            
            <span id="chunk-87" class="transcript-chunks" onclick="console.log('00:06:29,234'); seek(389.0)">
              Now, sulopenum offers significant therapeutic potential for the
            </span>
            
            <span id="chunk-88" class="transcript-chunks" onclick="console.log('00:06:34,394'); seek(394.0)">
              63 percent of patients with beta lactamase non susceptible infections.
            </span>
            
            <span id="chunk-89" class="transcript-chunks" onclick="console.log('00:06:39,584'); seek(399.0)">
              A population that was previously had limited treatment options
            </span>
            
            <span id="chunk-90" class="transcript-chunks" onclick="console.log('00:06:43,694'); seek(403.0)">
              due to antimicrobial resistance.
            </span>
            
            <span id="chunk-91" class="transcript-chunks" onclick="console.log('00:06:45,984'); seek(405.0)">
              The results are particularly promising for the 13.
            </span>
            
            <span id="chunk-92" class="transcript-chunks" onclick="console.log('00:06:48,814'); seek(408.0)">
              5 percent of patients with extended spectrum beta
            </span>
            
            <span id="chunk-93" class="transcript-chunks" onclick="console.log('00:06:52,994'); seek(412.0)">
              lactamase positive infections.
            </span>
            
            <span id="chunk-94" class="transcript-chunks" onclick="console.log('00:06:55,654'); seek(415.0)">
              As sulopenum provides a novel therapeutic approach that effectively overcomes
            </span>
            
            <span id="chunk-95" class="transcript-chunks" onclick="console.log('00:07:01,054'); seek(421.0)">
              traditional resistance mechanisms.
            </span>
            
            <span id="chunk-96" class="transcript-chunks" onclick="console.log('00:07:03,414'); seek(423.0)">
              This could play a crucial role in reducing dependence on last resort antibiotics,
            </span>
            
            <span id="chunk-97" class="transcript-chunks" onclick="console.log('00:07:11,364'); seek(431.0)">
              ultimately improving treatment outcomes and antimicrobial stewardship.
            </span>
            
            <span id="chunk-98" class="transcript-chunks" onclick="console.log('00:07:16,324'); seek(436.0)">
              Coming to future directions, further research is essential to
            </span>
            
            <span id="chunk-99" class="transcript-chunks" onclick="console.log('00:07:20,644'); seek(440.0)">
              explore personalized treatment approaches, gain deeper insights
            </span>
            
            <span id="chunk-100" class="transcript-chunks" onclick="console.log('00:07:24,974'); seek(444.0)">
              into resistance mechanisms.
            </span>
            
            <span id="chunk-101" class="transcript-chunks" onclick="console.log('00:07:27,069'); seek(447.0)">
              and refined clinical guidelines for UTI management.
            </span>
            
            <span id="chunk-102" class="transcript-chunks" onclick="console.log('00:07:31,429'); seek(451.0)">
              Additionally, conducting broader studies in diverse populations will be
            </span>
            
            <span id="chunk-103" class="transcript-chunks" onclick="console.log('00:07:35,769'); seek(455.0)">
              crucial to optimize treatment strategies in the face of rising antibiotic
            </span>
            
            <span id="chunk-104" class="transcript-chunks" onclick="console.log('00:07:40,649'); seek(460.0)">
              resistance, ensuring more effective and targeted therapeutic interventions.
            </span>
            
            <span id="chunk-105" class="transcript-chunks" onclick="console.log('00:07:47,059'); seek(467.0)">
              Now, finally, the key takeaways is that Celebenum has shown strong efficacy
            </span>
            
            <span id="chunk-106" class="transcript-chunks" onclick="console.log('00:07:53,289'); seek(473.0)">
              as an alternative to ciprofloxacin.
            </span>
            
            <span id="chunk-107" class="transcript-chunks" onclick="console.log('00:07:56,119'); seek(476.0)">
              particularly in drug resistant UTIs with over 90 percent, supports its
            </span>
            
            <span id="chunk-108" class="transcript-chunks" onclick="console.log('00:08:02,269'); seek(482.0)">
              role as a, sorry, with over a 90 percent success rates in ciprofloxacin
            </span>
            
            <span id="chunk-109" class="transcript-chunks" onclick="console.log('00:08:08,169'); seek(488.0)">
              non susceptible infections.
            </span>
            
            <span id="chunk-110" class="transcript-chunks" onclick="console.log('00:08:10,049'); seek(490.0)">
              It's excellent safety profile, with minimal adverse events and low
            </span>
            
            <span id="chunk-111" class="transcript-chunks" onclick="console.log('00:08:14,039'); seek(494.0)">
              discontinuation rates, supports its role as a first line treatment option.
            </span>
            
            <span id="chunk-112" class="transcript-chunks" onclick="console.log('00:08:19,769'); seek(499.0)">
              Moving forward, key priorities include integrating these findings
            </span>
            
            <span id="chunk-113" class="transcript-chunks" onclick="console.log('00:08:24,649'); seek(504.0)">
              into clinical guidelines, ongoing resistance surveillance, and
            </span>
            
            <span id="chunk-114" class="transcript-chunks" onclick="console.log('00:08:29,159'); seek(509.0)">
              developing targeted treatment protocols based on patient specific
            </span>
            
            <span id="chunk-115" class="transcript-chunks" onclick="console.log('00:08:32,819'); seek(512.0)">
              factors and pathogen susceptibility.
            </span>
            
            <span id="chunk-116" class="transcript-chunks" onclick="console.log('00:08:36,359'); seek(516.0)">
              These efforts are essential for enhancing antimicrobial stewardship
            </span>
            
            <span id="chunk-117" class="transcript-chunks" onclick="console.log('00:08:41,419'); seek(521.0)">
              and ensuring effective patient care amid rising antibiotic resistance.
            </span>
            
            <span id="chunk-118" class="transcript-chunks" onclick="console.log('00:08:47,389'); seek(527.0)">
              Thank you so much for giving me this opportunity.
            </span>
            
            </div>
          </div>
          
          

          
          <div class="col-12 mb-5">
            <h3>
              Slides
            </h3>
            <iframe src="https://conf42.github.io/static/slides/Karthik%20Akinapelli%20-%20Conf42%20Cloud%20Native%202025.pdf" width="100%" height="500px"></iframe>
            <a href="https://conf42.github.io/static/slides/Karthik%20Akinapelli%20-%20Conf42%20Cloud%20Native%202025.pdf" class="btn btn-xs btn-info shadow lift" style="background-color: #7B2726;" target="_blank">
              <i class="fe fe-paperclip me-2"></i>
              Download slides (PDF)
            </a>
          </div>
          

          <div class="col-12 mb-2 text-center">
            <div class="text-center mb-5">
              <a href="https://www.conf42.com/cloud2025" class="btn btn-sm btn-danger shadow lift" style="background-color: #7B2726;">
                <i class="fe fe-grid me-2"></i>
                See all 81 talks at this event!
              </a>
            </div>
          </div>
        </div> <!-- / .row -->
      </div> <!-- / .container -->
    </section>

    <!-- PHOTO -->
    <section class="pt-8 pb-6">
      <div class="container">

        <div class="row align-items-center">
          <div class="col-12 col-md-6 col-lg-7">

            <div class="mb-8 mb-md-0">

              <!-- Image -->
              <img src="https://conf42.github.io/static/headshots/Karthik%20Akinapelli_cloud.png" alt="..." class="screenshot img-fluid mw-md-110 float-end me-md-6 mb-6 mb-md-0">

            </div>

          </div>
          <div class="col-12 col-md-6 col-lg-5">

            <!-- List -->
            <div class="d-flex">

              <!-- Body -->
              <div class="ms-5">

                <!-- Author 1 -->
                <h2 class="me-2">
                  Karthik Akinapelli
                </h2>
                <h3 class="me-2">
                  <span class="text-muted">
                    Associate Director, Statistical Programing @ Takeda
                  </span>
                </h3>

                <p class="text-uppercase text-muted me-2 mb-3">
                  
                  <a href="https://www.linkedin.com/in/karthik-akinapelli-74200b20/" target="_blank" class="mr-3">
                    <img src="./assets/img/icons/social/linkedin.svg" class="list-social-icon" alt="Karthik Akinapelli's LinkedIn account" />
                  </a>
                  
                  
                </p>
                

                <br />

                <a
                  href="https://twitter.com/share?ref_src=twsrc%5Etfw"
                  class="twitter-share-button"

                  data-text="Check out this talk by Karthik Akinapelli"
                  data-url="https://www.conf42.com/cloud2025"
                  data-via="conf42com"
                  data-related=""
                  data-show-count="false"
                >
                  Tweet
                </a>
                <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

                <br />

                <script src="https://platform.linkedin.com/in.js" type="text/javascript">lang: en_US</script>
                <script type="IN/Share" data-url="https://www.conf42.com/cloud2025"></script>
              </div>

            </div>
          </div>
        </div> <!-- / .row -->
      </div> <!-- / .container -->
    </section>






    <!-- WELCOME -->
    <section class="pt-8 pt-md-11 pb-10 pb-md-15 bg-info" id="register">

      <!-- Shape -->
      <div class="shape shape-blur-3 text-white">
        <svg viewBox="0 0 1738 487" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M0 0h1420.92s713.43 457.505 0 485.868C707.502 514.231 0 0 0 0z" fill="url(#paint0_linear)"/><defs><linearGradient id="paint0_linear" x1="0" y1="0" x2="1049.98" y2="912.68" gradientUnits="userSpaceOnUse"><stop stop-color="currentColor" stop-opacity=".075"/><stop offset="1" stop-color="currentColor" stop-opacity="0"/></linearGradient></defs></svg>      </div>

      <!-- Content -->
      <div class="container">
        <div class="row justify-content-center">
          <div class="col-12 col-md-10 col-lg-8 text-center">

            <!-- Heading -->
            <h1 class="display-2 text-white">
              Join the community!
            </h1>

            <!-- Text -->
            <p class="lead text-white text-opacity-80 mb-6 mb-md-8">
              Learn for free, join the best tech learning community 
              for a <a class="text-white" href="https://www.reddit.com/r/sanfrancisco/comments/1bz90f6/why_are_coffee_shops_in_sf_so_expensive/" target="_blank">price of a pumpkin latte</a>.
            </p>

            <!-- Form -->
            <form class="d-flex align-items-center justify-content-center mb-7 mb-md-9">

              <!-- Label -->
              <span class="text-white text-opacity-80">
                Annual
              </span>

              <!-- Switch -->
              <div class="form-check form-check-dark form-switch mx-3">
                <input class="form-check-input" type="checkbox" id="billingSwitch" data-toggle="price" data-target=".price">
              </div>

              <!-- Label -->
              <span class="text-white text-opacity-80">
                Monthly
              </span>

            </form>

          </div>
        </div> <!-- / .row -->
      </div> <!-- / .container -->

    </section>

    <!-- SHAPE -->
    <div class="position-relative">
      <div class="shape shape-bottom shape-fluid-x text-light">
        <svg viewBox="0 0 2880 48" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M0 48h2880V0h-720C1442.5 52 720 0 720 0H0v48z" fill="currentColor"/></svg>      </div>
    </div>

    <!-- PRICING -->
    <section class="mt-n8 mt-md-n15">
      <div class="container">
        <div class="row gx-4">
          <div class="col-12 col-md-6">

            <!-- Card -->
            <div class="card shadow-lg mb-6 mb-md-1">
              <div class="card-body">

                <!-- Preheading -->
                <div class="text-center mb-3">
                  <span class="badge rounded-pill bg-primary-soft">
                    <span class="h6 text-uppercase">Newsletter</span>
                  </span>
                </div>

                <!-- Price -->
                <div class="d-flex justify-content-center">
                  <span class="h2 mb-0 mt-2">$</span>
                  <span class="price display-2 mb-0" data-annual="0" data-monthly="0">0</span>
                  <span class="h2 align-self-end mb-1">/mo</span>
                </div>

                <!-- Text -->
                <p class="text-center text-muted mb-5">
                </p>

              
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    Event notifications, weekly newsletter
                  </p>
                </div>
              
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    <b>Delayed access</b> to all content
                  </p>
                </div>
              
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    Immediate access to Keynotes & Panels
                  </p>
                </div>
              
              
              </div>
            </div>

            <!-- Card -->
            <div class="card shadow-lg mb-6 border border-success">
              <div class="card-body">

                <script>
    function gtag_report_conversion(url) {
      var callback = function () {
        if (typeof(url) != 'undefined') {
          window.location = url;
        }
      };
      gtag('event', 'conversion', {
          'send_to': 'AW-882275635/jLVTCPbt1N8CELPq2aQD',
          'event_callback': callback
      });
      return false;
    }
</script>

<!-- Form -->
<link rel="stylesheet" href="https://emailoctopus.com/bundles/emailoctopuslist/css/1.6/form.css">
<p class="emailoctopus-success-message text-success"></p>
<p class="emailoctopus-error-message text-danger"></p>
<form
    action="https://emailoctopus.com/lists/a3ba0cb5-7524-11eb-a3d0-06b4694bee2a/members/embedded/1.3/add"
    method="post"
    data-message-success="Thanks! Check your email for further directions!"
    data-message-missing-email-address="Your email address is required."
    data-message-invalid-email-address="Your email address looks incorrect, please try again."
    data-message-bot-submission-error="This doesn't look like a human submission."
    data-message-consent-required="Please check the checkbox to indicate your consent."
    data-message-invalid-parameters-error="This form has missing or invalid fields."
    data-message-unknown-error="Sorry, an unknown error has occurred. Please try again later."
    class="emailoctopus-form"
    data-sitekey="6LdYsmsUAAAAAPXVTt-ovRsPIJ_IVhvYBBhGvRV6"
>
<div class="form-floating emailoctopus-form-row">
    <input type="email" class="form-control form-control-flush" name="field_0" id="field_0" placeholder="Email" required>
    <label for="field_0">Email address</label>
</div>
<div class="form-floating emailoctopus-form-row">
    <input type="text" class="form-control form-control-flush" name="field_1" id="field_1" placeholder="First Name" required>
    <label for="field_1">First Name</label>
</div>
<div class="form-floating emailoctopus-form-row">
    <input type="text" class="form-control form-control-flush" name="field_2" id="field_2" placeholder="Last Name" required>
    <label for="field_2">Last Name</label>
</div>
<div class="form-floating emailoctopus-form-row">
    <input type="text" class="form-control form-control-flush" name="field_4" id="field_4" placeholder="Company" required>
    <label for="field_4">Company</label>
</div>
<div class="form-floating emailoctopus-form-row">
    <input type="text" class="form-control form-control-flush" name="field_5" id="field_5" placeholder="Job Title" required>
    <label for="field_5">Job Title</label>
</div>
<div class="form-floating emailoctopus-form-row">
    <input type="text" class="form-control form-control-flush" name="field_3" id="field_3" placeholder="Phone">
    <label for="field_3">Phone Number</label>
</div>
<div class="form-floating emailoctopus-form-row">
    <select type="text" class="form-control form-control-flush" name="field_7" id="country-source" required
    oninput="updateCountry()"
    >
    <!-- Country names and Country Name -->
    <option value="">Please select your country</option>
    <option value="Afghanistan">Afghanistan</option>
    <option value="Aland Islands">Aland Islands</option>
    <option value="Albania">Albania</option>
    <option value="Algeria">Algeria</option>
    <option value="American Samoa">American Samoa</option>
    <option value="Andorra">Andorra</option>
    <option value="Angola">Angola</option>
    <option value="Anguilla">Anguilla</option>
    <option value="Antarctica">Antarctica</option>
    <option value="Antigua and Barbuda">Antigua and Barbuda</option>
    <option value="Argentina">Argentina</option>
    <option value="Armenia">Armenia</option>
    <option value="Aruba">Aruba</option>
    <option value="Australia">Australia</option>
    <option value="Austria">Austria</option>
    <option value="Azerbaijan">Azerbaijan</option>
    <option value="Bahamas">Bahamas</option>
    <option value="Bahrain">Bahrain</option>
    <option value="Bangladesh">Bangladesh</option>
    <option value="Barbados">Barbados</option>
    <option value="Belarus">Belarus</option>
    <option value="Belgium">Belgium</option>
    <option value="Belize">Belize</option>
    <option value="Benin">Benin</option>
    <option value="Bermuda">Bermuda</option>
    <option value="Bhutan">Bhutan</option>
    <option value="Bolivia">Bolivia</option>
    <option value="Bonaire, Sint Eustatius and Saba">Bonaire, Sint Eustatius and Saba</option>
    <option value="Bosnia and Herzegovina">Bosnia and Herzegovina</option>
    <option value="Botswana">Botswana</option>
    <option value="Bouvet Island">Bouvet Island</option>
    <option value="Brazil">Brazil</option>
    <option value="British Indian Ocean Territory">British Indian Ocean Territory</option>
    <option value="Brunei Darussalam">Brunei Darussalam</option>
    <option value="Bulgaria">Bulgaria</option>
    <option value="Burkina Faso">Burkina Faso</option>
    <option value="Burundi">Burundi</option>
    <option value="Cambodia">Cambodia</option>
    <option value="Cameroon">Cameroon</option>
    <option value="Canada">Canada</option>
    <option value="Cape Verde">Cape Verde</option>
    <option value="Cayman Islands">Cayman Islands</option>
    <option value="Central African Republic">Central African Republic</option>
    <option value="Chad">Chad</option>
    <option value="Chile">Chile</option>
    <option value="China">China</option>
    <option value="Christmas Island">Christmas Island</option>
    <option value="Cocos (Keeling) Islands">Cocos (Keeling) Islands</option>
    <option value="Colombia">Colombia</option>
    <option value="Comoros">Comoros</option>
    <option value="Congo">Congo</option>
    <option value="Congo, Democratic Republic of the Congo">Congo, Democratic Republic of the Congo</option>
    <option value="Cook Islands">Cook Islands</option>
    <option value="Costa Rica">Costa Rica</option>
    <option value="Cote D'Ivoire">Cote D'Ivoire</option>
    <option value="Croatia">Croatia</option>
    <option value="Cuba">Cuba</option>
    <option value="Curacao">Curacao</option>
    <option value="Cyprus">Cyprus</option>
    <option value="Czech Republic">Czech Republic</option>
    <option value="Denmark">Denmark</option>
    <option value="Djibouti">Djibouti</option>
    <option value="Dominica">Dominica</option>
    <option value="Dominican Republic">Dominican Republic</option>
    <option value="Ecuador">Ecuador</option>
    <option value="Egypt">Egypt</option>
    <option value="El Salvador">El Salvador</option>
    <option value="Equatorial Guinea">Equatorial Guinea</option>
    <option value="Eritrea">Eritrea</option>
    <option value="Estonia">Estonia</option>
    <option value="Ethiopia">Ethiopia</option>
    <option value="Falkland Islands (Malvinas)">Falkland Islands (Malvinas)</option>
    <option value="Faroe Islands">Faroe Islands</option>
    <option value="Fiji">Fiji</option>
    <option value="Finland">Finland</option>
    <option value="France">France</option>
    <option value="French Guiana">French Guiana</option>
    <option value="French Polynesia">French Polynesia</option>
    <option value="French Southern Territories">French Southern Territories</option>
    <option value="Gabon">Gabon</option>
    <option value="Gambia">Gambia</option>
    <option value="Georgia">Georgia</option>
    <option value="Germany">Germany</option>
    <option value="Ghana">Ghana</option>
    <option value="Gibraltar">Gibraltar</option>
    <option value="Greece">Greece</option>
    <option value="Greenland">Greenland</option>
    <option value="Grenada">Grenada</option>
    <option value="Guadeloupe">Guadeloupe</option>
    <option value="Guam">Guam</option>
    <option value="Guatemala">Guatemala</option>
    <option value="Guernsey">Guernsey</option>
    <option value="Guinea">Guinea</option>
    <option value="Guinea-Bissau">Guinea-Bissau</option>
    <option value="Guyana">Guyana</option>
    <option value="Haiti">Haiti</option>
    <option value="Heard Island and Mcdonald Islands">Heard Island and Mcdonald Islands</option>
    <option value="Holy See (Vatican City State)">Holy See (Vatican City State)</option>
    <option value="Honduras">Honduras</option>
    <option value="Hong Kong">Hong Kong</option>
    <option value="Hungary">Hungary</option>
    <option value="Iceland">Iceland</option>
    <option value="India">India</option>
    <option value="Indonesia">Indonesia</option>
    <option value="Iran, Islamic Republic of">Iran, Islamic Republic of</option>
    <option value="Iraq">Iraq</option>
    <option value="Ireland">Ireland</option>
    <option value="Isle of Man">Isle of Man</option>
    <option value="Israel">Israel</option>
    <option value="Italy">Italy</option>
    <option value="Jamaica">Jamaica</option>
    <option value="Japan">Japan</option>
    <option value="Jersey">Jersey</option>
    <option value="Jordan">Jordan</option>
    <option value="Kazakhstan">Kazakhstan</option>
    <option value="Kenya">Kenya</option>
    <option value="Kiribati">Kiribati</option>
    <option value="Korea, Democratic People's Republic of">Korea, Democratic People's Republic of</option>
    <option value="Korea, Republic of">Korea, Republic of</option>
    <option value="Kosovo">Kosovo</option>
    <option value="Kuwait">Kuwait</option>
    <option value="Kyrgyzstan">Kyrgyzstan</option>
    <option value="Lao People's Democratic Republic">Lao People's Democratic Republic</option>
    <option value="Latvia">Latvia</option>
    <option value="Lebanon">Lebanon</option>
    <option value="Lesotho">Lesotho</option>
    <option value="Liberia">Liberia</option>
    <option value="Libyan Arab Jamahiriya">Libyan Arab Jamahiriya</option>
    <option value="Liechtenstein">Liechtenstein</option>
    <option value="Lithuania">Lithuania</option>
    <option value="Luxembourg">Luxembourg</option>
    <option value="Macao">Macao</option>
    <option value="Macedonia, the Former Yugoslav Republic of">Macedonia, the Former Yugoslav Republic of</option>
    <option value="Madagascar">Madagascar</option>
    <option value="Malawi">Malawi</option>
    <option value="Malaysia">Malaysia</option>
    <option value="Maldives">Maldives</option>
    <option value="Mali">Mali</option>
    <option value="Malta">Malta</option>
    <option value="Marshall Islands">Marshall Islands</option>
    <option value="Martinique">Martinique</option>
    <option value="Mauritania">Mauritania</option>
    <option value="Mauritius">Mauritius</option>
    <option value="Mayotte">Mayotte</option>
    <option value="Mexico">Mexico</option>
    <option value="Micronesia, Federated States of">Micronesia, Federated States of</option>
    <option value="Moldova, Republic of">Moldova, Republic of</option>
    <option value="Monaco">Monaco</option>
    <option value="Mongolia">Mongolia</option>
    <option value="Montenegro">Montenegro</option>
    <option value="Montserrat">Montserrat</option>
    <option value="Morocco">Morocco</option>
    <option value="Mozambique">Mozambique</option>
    <option value="Myanmar">Myanmar</option>
    <option value="Namibia">Namibia</option>
    <option value="Nauru">Nauru</option>
    <option value="Nepal">Nepal</option>
    <option value="Netherlands">Netherlands</option>
    <option value="Netherlands Antilles">Netherlands Antilles</option>
    <option value="New Caledonia">New Caledonia</option>
    <option value="New Zealand">New Zealand</option>
    <option value="Nicaragua">Nicaragua</option>
    <option value="Niger">Niger</option>
    <option value="Nigeria">Nigeria</option>
    <option value="Niue">Niue</option>
    <option value="Norfolk Island">Norfolk Island</option>
    <option value="Northern Mariana Islands">Northern Mariana Islands</option>
    <option value="Norway">Norway</option>
    <option value="Oman">Oman</option>
    <option value="Pakistan">Pakistan</option>
    <option value="Palau">Palau</option>
    <option value="Palestinian Territory, Occupied">Palestinian Territory, Occupied</option>
    <option value="Panama">Panama</option>
    <option value="Papua New Guinea">Papua New Guinea</option>
    <option value="Paraguay">Paraguay</option>
    <option value="Peru">Peru</option>
    <option value="Philippines">Philippines</option>
    <option value="Pitcairn">Pitcairn</option>
    <option value="Poland">Poland</option>
    <option value="Portugal">Portugal</option>
    <option value="Puerto Rico">Puerto Rico</option>
    <option value="Qatar">Qatar</option>
    <option value="Reunion">Reunion</option>
    <option value="Romania">Romania</option>
    <option value="Russian Federation">Russian Federation</option>
    <option value="Rwanda">Rwanda</option>
    <option value="Saint Barthelemy">Saint Barthelemy</option>
    <option value="Saint Helena">Saint Helena</option>
    <option value="Saint Kitts and Nevis">Saint Kitts and Nevis</option>
    <option value="Saint Lucia">Saint Lucia</option>
    <option value="Saint Martin">Saint Martin</option>
    <option value="Saint Pierre and Miquelon">Saint Pierre and Miquelon</option>
    <option value="Saint Vincent and the Grenadines">Saint Vincent and the Grenadines</option>
    <option value="Samoa">Samoa</option>
    <option value="San Marino">San Marino</option>
    <option value="Sao Tome and Principe">Sao Tome and Principe</option>
    <option value="Saudi Arabia">Saudi Arabia</option>
    <option value="Senegal">Senegal</option>
    <option value="Serbia">Serbia</option>
    <option value="Serbia and Montenegro">Serbia and Montenegro</option>
    <option value="Seychelles">Seychelles</option>
    <option value="Sierra Leone">Sierra Leone</option>
    <option value="Singapore">Singapore</option>
    <option value="Sint Maarten">Sint Maarten</option>
    <option value="Slovakia">Slovakia</option>
    <option value="Slovenia">Slovenia</option>
    <option value="Solomon Islands">Solomon Islands</option>
    <option value="Somalia">Somalia</option>
    <option value="South Africa">South Africa</option>
    <option value="South Georgia and the South Sandwich Islands">South Georgia and the South Sandwich Islands</option>
    <option value="South Sudan">South Sudan</option>
    <option value="Spain">Spain</option>
    <option value="Sri Lanka">Sri Lanka</option>
    <option value="Sudan">Sudan</option>
    <option value="Suriname">Suriname</option>
    <option value="Svalbard and Jan Mayen">Svalbard and Jan Mayen</option>
    <option value="Swaziland">Swaziland</option>
    <option value="Sweden">Sweden</option>
    <option value="Switzerland">Switzerland</option>
    <option value="Syrian Arab Republic">Syrian Arab Republic</option>
    <option value="Taiwan, Province of China">Taiwan, Province of China</option>
    <option value="Tajikistan">Tajikistan</option>
    <option value="Tanzania, United Republic of">Tanzania, United Republic of</option>
    <option value="Thailand">Thailand</option>
    <option value="Timor-Leste">Timor-Leste</option>
    <option value="Togo">Togo</option>
    <option value="Tokelau">Tokelau</option>
    <option value="Tonga">Tonga</option>
    <option value="Trinidad and Tobago">Trinidad and Tobago</option>
    <option value="Tunisia">Tunisia</option>
    <option value="Turkey">Turkey</option>
    <option value="Turkmenistan">Turkmenistan</option>
    <option value="Turks and Caicos Islands">Turks and Caicos Islands</option>
    <option value="Tuvalu">Tuvalu</option>
    <option value="Uganda">Uganda</option>
    <option value="Ukraine">Ukraine</option>
    <option value="United Arab Emirates">United Arab Emirates</option>
    <option value="United Kingdom">United Kingdom</option>
    <option value="United States">United States</option>
    <option value="United States Minor Outlying Islands">United States Minor Outlying Islands</option>
    <option value="Uruguay">Uruguay</option>
    <option value="Uzbekistan">Uzbekistan</option>
    <option value="Vanuatu">Vanuatu</option>
    <option value="Venezuela">Venezuela</option>
    <option value="Viet Nam">Viet Nam</option>
    <option value="Virgin Islands, British">Virgin Islands, British</option>
    <option value="Virgin Islands, U.s.">Virgin Islands, U.s.</option>
    <option value="Wallis and Futuna">Wallis and Futuna</option>
    <option value="Western Sahara">Western Sahara</option>
    <option value="Yemen">Yemen</option>
    <option value="Zambia">Zambia</option>
    <option value="Zimbabwe">Zimbabwe</option>
    </select>
    <label for="field_7">Country</label>
</div>
<input id="country-destination" name="field_7" type="hidden">
<input id="tz-country" name="field_8" type="hidden">

<input
    name="field_6"
    type="hidden"
    value="Cloud Native"
>

<div class="emailoctopus-form-row-consent">
    <input
    type="checkbox"
    id="consent"
    name="consent"
    >
    <label for="consent">
    I consent to the following terms:
    </label>
    <a href="https://www.conf42.com/terms-and-conditions.pdf" target="_blank">
    Terms and Conditions
    </a>
    &amp;
    <a href="./code-of-conduct" target="_blank">
    Code of Conduct
    </a>
</div>
<div
    aria-hidden="true"
    class="emailoctopus-form-row-hp"
>
    <input
    type="text"
    name="hpc4b27b6e-eb38-11e9-be00-06b4694bee2a"
    tabindex="-1"
    autocomplete="nope"
    >
</div>
<div class="mt-6 emailoctopus-form-row-subscribe">
    <input
    type="hidden"
    name="successRedirectUrl"
    >
    <button class="btn w-100 btn-success lift" type="submit" onclick="gtag_report_conversion(); rdt('track', 'SignUp');">
    Subscribe to free newsletter <i class="fe fe-arrow-right ms-3"></i>
    </button>
</div>
</form>

<!-- <script src="https://emailoctopus.com/bundles/emailoctopuslist/js/1.6/form-recaptcha.js"></script> -->
<script src="https://emailoctopus.com/bundles/emailoctopuslist/js/1.6/form-embed.js"></script>

              </div>
            </div>
          </div>
          <div class="col-12 col-md-6">

            <!-- Card -->
            <div class="card shadow-lg mb-6 mb-md-0">
              <div class="card-body">

                <!-- Preheading -->
                <div class="text-center mb-3">
                  <span class="badge rounded-pill bg-primary-soft">
                    <span class="h6 text-uppercase">Community</span>
                  </span>
                </div>

                <!-- Price -->
                <div class="d-flex justify-content-center">
                  <span class="h2 mb-0 mt-2">$</span>
                  <span class="price display-2 mb-0" data-annual="8.34" data-monthly="10">8.34</span>
                  <span class="h2 align-self-end mb-1">/mo</span>
                </div>

                <!-- Text -->
                <p class="text-center text-muted mb-5">
                </p>

                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    Access to <a href="https://conf42.circle.so/">Circle community platform</a>
                  </p>
                </div>

                
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    <b>Immediate access</b> to all content
                  </p>
                </div>
                
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    <a href="https://conf42.circle.so/c/live-events/" target="_blank"><b>Live events!</b></a>
                  </p>
                </div>
                
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    <a href="https://conf42.circle.so/c/live-events/" target="_blank">Regular office hours, Q&As, CV reviews</a>
                  </p>
                </div>
                
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    Courses, quizes & certificates
                  </p>
                </div>
                
                <div class="d-flex">
                  <div class="badge badge-rounded-circle bg-success-soft mt-1 me-4">
                    <i class="fe fe-check"></i>
                  </div>
                  <p>
                    Community chats
                  </p>
                </div>
                

                <!-- Button -->
                <a href="https://conf42.circle.so/checkout/subscribe" class="btn w-100 btn-primary">
                  Join the community (7 day free trial)<i class="fe fe-arrow-right ms-3"></i>
                </a>

              </div>
            </div>

          </div>
        </div> <!-- / .row -->
      </div> <!-- / .container -->
    </section>

    <!-- SHAPE -->
    <div class="position-relative">
      <div class="shape shape-bottom shape-fluid-x svg-shim text-dark">
        <svg viewBox="0 0 2880 48" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M0 48h2880V0h-720C1442.5 52 720 0 720 0H0v48z" fill="currentColor"/></svg>      </div>
    </div>

    <!-- FOOTER -->
    <footer class="py-8 py-md-11 bg-dark">
      <div class="container">
        <div class="row">

          <div class="col-12 col-md-4 col-lg-3">
            <!-- Brand -->
            <img src="./assets/conf42/conf42_logo_white_small.png" alt="..." class="footer-brand img-fluid mb-2">
    
            <!-- Text -->
            <p class="text-gray-700 mb-2">
              Online tech events
            </p>
    
            <!-- Social -->
            <ul class="list-unstyled list-inline list-social mb-5">
              <li class="list-inline-item list-social-item me-3">
                <a href="https://www.linkedin.com/company/49110720/" class="text-decoration-none">
                  <img src="./assets/img/icons/social/linkedin.svg" class="list-social-icon" alt="...">
                </a>
              </li>
              <li class="list-inline-item list-social-item me-3">
                <a href="https://twitter.com/conf42com" class="text-decoration-none">
                  <img src="./assets/img/icons/social/twitter.svg" class="list-social-icon" alt="...">
                </a>
              </li>
            </ul>

            <!-- QR Code -->
            <img src="./assets/conf42/CONF42.QR.png" style="width: 100px;" class="mb-5 img-fluid" />
          </div>


          <div class="col-12 col-md-4 col-lg-3">
          
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Events 2025
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-6 mb-md-8 mb-lg-0">
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devops2025">
                  DevOps 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/python2025">
                  Python 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ce2025">
                  Chaos Engineering 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/cloud2025">
                  Cloud Native 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/llms2025">
                  Large Language Models (LLMs) 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/golang2025">
                  Golang 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/sre2025">
                  Site Reliability Engineering (SRE) 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ml2025">
                  Machine Learning 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/obs2025">
                  Observability 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/quantum2025">
                  Quantum Computing 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/rustlang2025">
                  Rustlang 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/platform2025">
                  Platform Engineering 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/mlops2025">
                  MLOps 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/im2025">
                  Incident Management 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/kubenative2025">
                  Kube Native 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/js2025">
                  JavaScript 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/prompt2025">
                  Prompt Engineering 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/robotics2025">
                  Robotics 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devsecops2025">
                  DevSecOps 2025
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/iot2025">
                  Internet of Things (IoT) 2025
                </a>
              </li>
            
            </ul>
          
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Events 2024
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-6 mb-md-8 mb-lg-0">
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devops2024">
                  DevOps 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ce2024">
                  Chaos Engineering 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/python2024">
                  Python 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/cloud2024">
                  Cloud Native 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/llms2024">
                  Large Language Models (LLMs) 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/golang2024">
                  Golang 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/sre2024">
                  Site Reliability Engineering (SRE) 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ml2024">
                  Machine Learning 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/obs2024">
                  Observability 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/quantum2024">
                  Quantum Computing 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/rustlang2024">
                  Rustlang 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/platform2024">
                  Platform Engineering 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/kubenative2024">
                  Kube Native 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/im2024">
                  Incident Management 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/js2024">
                  JavaScript 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/prompt2024">
                  Prompt Engineering 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devsecops2024">
                  DevSecOps 2024
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/iot2024">
                  Internet of Things (IoT) 2024
                </a>
              </li>
            
            </ul>
          
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Events 2023
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-6 mb-md-8 mb-lg-0">
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devops2023">
                  DevOps 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ce2023">
                  Chaos Engineering 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/python2023">
                  Python 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/cloud2023">
                  Cloud Native 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/golang2023">
                  Golang 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/sre2023">
                  Site Reliability Engineering 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ml2023">
                  Machine Learning 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/obs2023">
                  Observability 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/quantum2023">
                  Quantum Computing 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/rustlang2023">
                  Rustlang 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/platform2023">
                  Platform Engineering 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/kubenative2023">
                  Kube Native 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/im2023">
                  Incident Management 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/js2023">
                  JavaScript 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devsecops2023">
                  DevSecOps 2023
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/iot2023">
                  Internet of Things (IoT) 2023
                </a>
              </li>
            
            </ul>
          
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Events 2022
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-6 mb-md-8 mb-lg-0">
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/python2022">
                  Python 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/mobile2022">
                  Mobile 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ce2022">
                  Chaos Engineering 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/golang2022">
                  Golang 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/cloud2022">
                  Cloud Native 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ml2022">
                  Machine Learning 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/sre2022">
                  Site Reliability Engineering 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/quantum2022">
                  Quantum Computing 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/rustlang2022">
                  Rustlang 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/im2022">
                  Incident Management 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/kubenative2022">
                  Kube Native 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/js2022">
                  JavaScript 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devsecops2022">
                  DevSecOps 2022
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/web2022">
                  Web 3.0 2022
                </a>
              </li>
            
            </ul>
          
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Events 2021
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-6 mb-md-8 mb-lg-0">
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ce2021">
                  Chaos Engineering 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/enterprise2021">
                  Enterprise Software 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/cloud2021">
                  Cloud Native 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/python2021">
                  Python 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/golang2021">
                  Golang 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ml2021">
                  Machine Learning 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/sre2021">
                  Site Reliability Engineering 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/js2021">
                  JavaScript 2021
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/devsecops2021">
                  DevSecOps 2021
                </a>
              </li>
            
            </ul>
          
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Events 2020
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-6 mb-md-8 mb-lg-0">
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/ce2020">
                  Chaos Engineering 2020
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/oss2020">
                  Open Source Showcase 2020
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/sre2020">
                  Site Reliability Engineering 2020
                </a>
              </li>
            
              <li class="mb-3">
                <a class="text-reset" href="https://www.conf42.com/js2020">
                  JavaScript 2020
                </a>
              </li>
            
            </ul>
          
          </div>

          
          <div class="col-12 col-md-4 offset-md-4 col-lg-3 offset-lg-0">

            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Community
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-0">
              <li class="mb-3">
                <a href="./support" class="text-reset">
                  Support us
                </a>
              </li>
              <li class="mb-3">
                <a href="./speakers" class="text-reset">
                  Speakers
                </a>
              </li>
              <li class="mb-3">
                <a href="./hall-of-fame" class="text-reset">
                  Hall of fame
                </a>
              </li>
              <li class="mb-3">
                <a href="https://discord.gg/DnyHgrC7jC" class="text-reset" target="_blank">
                  Discord
                </a>
              </li>
              <li class="mb-3">
                <a href="./about" class="text-reset">
                  About the team
                </a>
              </li>
            </ul>

            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Sponsors
            </h6>
            <!-- List -->
            <ul class="list-unstyled text-muted mb-0">
              <li class="mb-3">
                <a href="./sponsor" class="text-reset" target="_blank">
                  Sponsorship
                </a>
              </li>
              <li class="mb-3">
                <a href="mailto:mark@conf42.com?subject=We would like to sponsor" class="text-reset" target="_blank">
                  Request the Prospectus
                </a>
              </li>
              <li class="mb-3">
                <a href="https://drive.google.com/drive/folders/1tT2lspLQgj3sdfxG9FwDVkBUt-TYSPGe?usp=sharing" class="text-reset" target="_blank">
                  Media kit
                </a>
              </li>
            </ul>
    
          </div>


          <div class="col-12 col-md-4 col-lg-3">
    
            <!-- Heading -->
            <h6 class="fw-bold text-uppercase text-gray-700">
              Legal
            </h6>
    
            <!-- List -->
            <ul class="list-unstyled text-muted mb-0">
              <li class="mb-3">
                <a href="./code-of-conduct" class="text-reset">
                  Code of Conduct
                </a>
              </li>
              <li class="mb-3">
                <a href="https://www.conf42.com/terms-and-conditions.pdf" class="text-reset" target="_blank">
                  Terms and Conditions
                </a>
              </li>
              <li class="mb-3">
                <a href="https://www.conf42.com/privacy-policy.pdf" class="text-reset" target="_blank">
                  Privacy policy
                </a>
              </li>
            </ul>
          </div>


        </div> <!-- / .row -->
      </div> <!-- / .container -->
    </footer>

    <!-- JAVASCRIPT -->
    <!-- Map JS -->
    <script src='https://api.mapbox.com/mapbox-gl-js/v0.53.0/mapbox-gl.js'></script>
    
    <!-- Vendor JS -->
    <script src="./assets/js/vendor.bundle.js"></script>
    
    <!-- Theme JS -->
    <script src="./assets/js/theme.bundle.js"></script>

    <!-- Various JS -->
    <script src="./assets/js/various.js"></script>

    <script src='https://cdn.jsdelivr.net/npm/@widgetbot/crate@3' async defer>
      new Crate({
          notifications: true,
          indicator: true,
          server: '814240231606714368', // Conf42.com
          channel: '814240231788249115' // #community
      })
    </script>
  </body>
</html>